Method for preparing nicotinamide mononucleotide
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 湖州颐盛生物科技有限公司
- Publication Date
- 2021-01-01
Smart Images

Figure 1
Abstract
Description
Technical field
[0001] The invention belongs to the technical field of biocatalysis, and relates to a method for preparing nicotinamide mononucleotide, and specifically, to a new method for enzymatically synthesizing nicotinamide mononucleotide.Background technique
[0002] Nicotinamide mononucleotide (β-Nicotinamide mononucleotide, referred to as β-NMN or NMN) is an endogenous substance in the human body. It is the product of nicotinamide phosphoribosyl transferase reaction and participates in intracellular nicotinamide purine dinucleoside Acid (NAD+The synthesis of) is its important and most direct prerequisite substance. In the human body, NMN is converted into NAD+Exercising its physiological functions, such as activating NAD+The substrate-dependent enzyme Sirt1 (histone deacetylase, also known as sirtuin), regulates cell survival and death, and maintains redox state. But it will gradually decrease with age. Thanks to NAD+The molecular weight is too large to be absorbed by the human b...